Rb and N-ras Function Together To Control Differentiation in the Mouse

REFERENCES

• Bos, J. L. 1989. ras oncogenes in human cancer: a review. Cancer Res. 49: 4682–4689.
   PubMed Web of Science ®Google Scholar
• Ceol, C. J., and H. R. Horvitz. 2001. dpl-1 DP and efl-1 E2F act with lin-35 Rb to antagonize Ras signaling in C. elegans vulval development. Mol. Cell 7: 461–473.
   PubMedGoogle Scholar
• Chen, P.-L., D. J. Riley, Y. Chen, and W.-H. Lee. 1996. Retinoblastoma protein positively regulates terminal adipocyte differentiation through direct interaction with C/EBPs. Genes Dev. 10: 2794–2804.
   PubMedGoogle Scholar
• Chen, P.-L., D. J. Riley, S. Chen-Kiang, and W.-H. Lee. 1996. Retinoblastoma protein directly interacts with and activates the transcription factor NF-IL6. Proc. Natl. Acad. Sci. USA 93: 465–469.
   PubMedGoogle Scholar
• Clarke, A. R., E. R. Maandag, M. van Roon, N. M. T. van der Lugt, M. van der Valk, M. L. Hooper, A. Berns, and H. te Riele. 1992. Requirement for a functional Rb-1 gene in murine development. Nature 359: 328–330.
   PubMed Web of Science ®Google Scholar
• Classon, M., B. K. Kennedy, R. Mulloy, and E. Harlow. 2000. Opposing roles of pRB and p107 in adipocyte differentiation. Proc. Natl. Acad. Sci. USA 97: 10826–10831.
   PubMed Web of Science ®Google Scholar
• Cole, T. J., J. A. Blendy, P. Monaghan, K. Krieglstein, S. W., A. Aguzzi, G. Fantuzzi, E. Hummler, K. Unsicker, and G. Schutz. 1995. Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes Dev. 9: 1608–1621.
   PubMed Web of Science ®Google Scholar
• Esteban, L. M., C. Vicario-Abejon, P. Fernandez-Salguero, A. Fernandez-Medarde, N. Swaminathan, K. Yienger, E. Lopez, M. Malumbres, R. McKay, J. M. Ward, A. Pellicer, and E. Santos. 2001. Targeted genomic disruption of H-ras and N-ras, individually or in combination, reveals the dispensability of both loci for mouse growth and development. Mol. Cell. Biol. 21: 1444–1452.
   PubMed Web of Science ®Google Scholar
• Freshney, R. I. 2000. Culture of animal cells: a manual of basic technique, 4th ed. Wiley-Liss, New York, N.Y.
   Google Scholar
• Gaubatz, S., G. J. Lindeman, S. Ishida, L. Jakoi, J. R. Nevins, D. M. Livingston, and R. E. Rempel. 2000. E2F4 and E2F5 play an essential role in pocket protein-mediated G1 control. Mol. Cell 6: 729–735.
   PubMed Web of Science ®Google Scholar
• Gu, W., J. W. Schneider, G. Condorelli, S. Kaushal, V. Mahdavi, and B. Nadal-Ginard. 1993. Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell 72: 309–324.
   PubMed Web of Science ®Google Scholar
• Hansen, J. B., R. K. Petersen, C. Jorgensen, and K. Kristiansen. 2002. Deregulated MAPK activity prevents adipocyte differentiation in fibroblasts lacking the retinoblastoma protein. J. Biol. Chem. 277: 26335–26339.
   PubMed Web of Science ®Google Scholar
• Harbour, J. W., and D. C. Dean. 2000. Rb function in cell-cycle regulation and apoptosis. Nat. Cell Biol. 2: E65–E67.
   PubMed Web of Science ®Google Scholar
• Harbour, J. W., and D. C. Dean. 2000. The Rb/E2F pathway: expanding roles and emerging paradigms. Genes Dev. 14: 2393–2409.
   PubMed Web of Science ®Google Scholar
• Harrison, D. J., M. L. Hooper, J. F. Armstrong, and A. R. Clarke. 1995. Effects of heterozygosity for the Rb-1t19neo allele in the mouse. Oncogene 20: 1615–1620.
   Google Scholar
• Hock, J. R., A. Ziemiecki, R. Klemenz, R. Friis, and B. Groner. 1989. Oncogene mediated repression of glucocorticoid hormone response elements and glucocorticoid receptor levels. Cancer Res. 49: 2266s-2274s.
   PubMedGoogle Scholar
• Hu, N., A. Gutsmann, D. C. Herbert, A. Bradley, W.-H. Lee, and E. Y. Lee. 1994. Heterozygous Rb-1 delta 20/+ mice are predisposed to tumors of the pituitary gland with a nearly complete penetrance. Oncogene 9: 1021–1027.
   PubMedGoogle Scholar
• Ise, K., K. Kakamura, K. Nakao, S. Shimizu, H. Harada, T. Ichise, J. Miyoshi, Y. Gondo, T. Ishikawa, A. Aiba, and M. Katsuki. 2000. Targeted deletion of H-ras gene decreases tumor formation in mouse skin carcinogenesis. Oncogene 19: 2951–2956.
   PubMed Web of Science ®Google Scholar
• Jacks, T., A. Fazeli, E. M. Schmitt, R. T. Bronson, M. A. Goodell, and R. A. Weinberg. 1992. Effects of an Rb mutation in the mouse. Nature 359: 295–300.
   PubMed Web of Science ®Google Scholar
• Jiang, Z., Z. Guo, F. A. Saad, J. Ellis, and E. Zacksenhaus. 2001. Retinoblastoma gene promoter directs transgene expression exclusively to the nervous system. J. Biol. Chem. 276: 593–600.
   PubMedGoogle Scholar
• Jiang, Z., P. Liang, R. Leng, Z. Guo, Y. Liu, X. Liu, S. Bubnic, A. Keating, D. Murray, P. Goss, and E. Zacksenhaus. 2000. E2F1 and p53 are dispensable, whereas p21Waf1/Cip1 cooperates with Rb to restrict endoreduplication and apoptosis during skeletal myogenesis. Dev. Biol. 227: 28–41.
   Google Scholar
• Johnson, L., D. Greenbaum, K. Cichowski, K. Mercer, E. Murphy, E. Schmitt, R. T. Bronson, H. Umanoff, E. Windfried, R. Kucherlapati, and T. Jacks. 1997. K-ras is an essential gene in the mouse with partial functional overlap with N-ras. Genes Dev. 11: 2468–2481.
   PubMed Web of Science ®Google Scholar
• Jones, M. K., and J. H. Jackson. 1998. Ras-GRF activates Ha-Ras, but not N-Ras or K-Ras 4B, protein in vivo. J. Biol. Chem. 273: 1782–1787.
   PubMed Web of Science ®Google Scholar
• Khosravi-Far, R., and C. J. Der. 1994. The Ras signal transduction pathway. Cancer Metastasis Rev. 13: 67–89.
   PubMed Web of Science ®Google Scholar
• Koera, K., K. Nakamura, K. Nakao, J. Miyoshi, K. Toyoshima, T. Hatta, H. Otani, A. Aiba, and M. Katsuki. 1997. K-Ras is essential for the development of the mouse embryo. Oncogene 15: 1151–1159.
   PubMed Web of Science ®Google Scholar
• Kong, Y., S. E. Johnson, E. J. Taparowsky, and S. F. Konieczny. 1995. Ras p21Val inhibits myogenesis without altering the DNA binding or transcriptional activities of the myogenic basic helix-loop-helix factors. Mol. Cell. Biol. 15: 5205–5213.
   PubMedGoogle Scholar
• Kowenz-Leutz, E., G. Twamley, S. Ansieau, and A. Leutz. 1994. Novel mechanism of C/EBPβ (NF-M) transcriptional control: activation through derepression. Genes Dev. 8: 2781–2791.
   PubMed Web of Science ®Google Scholar
• Kratzke, R. A., G. A. Otterson, A. Hogg, A. B. Coxon, J. Geradts, J. K. Cowell, and F. J. Kaye. 1994. Partial inactivation of RB product in a family with incomplete penetrance of familial retinoblastoma and benign retinal tumors. Oncogene 9: 1321–1326.
   PubMed Web of Science ®Google Scholar
• Lamb, J., M. H. Ladha, C. McMahon, R. L. Sutherland, and M. E. Ewen. 2000. Regulation of the functional interaction between cyclin D1 and the estrogen receptor. Mol. Cell. Biol. 20: 8667–8675.
   PubMedGoogle Scholar
• Lasorella, A., M. Noseda, M. Beyna, and A. Iavarone. 2000. Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins. Nature 407: 592–598.
   PubMed Web of Science ®Google Scholar
• Lee, E. Y.-H. P., C.-Y. Chang, N. Hu, Y.-C. J. Wang, C.-C. Lai, K. Herrup, W.-H. Lee, and A. Bradley. 1992. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 359: 288–294.
   PubMed Web of Science ®Google Scholar
• Lee, E. Y.-H. P., N. Hu, S.-S. F. Yuan, L. A. Cox, A. Bradley, W.-H. Lee, and K. Herrup. 1994. Dual roles of the retinoblastoma protein in cell cycle regulation and neuron differentiation. Genes Dev. 8: 2008–2021.
   PubMed Web of Science ®Google Scholar
• Lee, K. Y., M. H. Ladha, C. McMahon, and M. E. Ewen. 1999. The retinoblastoma protein is linked to the activation of Ras. Mol. Cell. Biol. 19: 7724–7732.
   PubMed Web of Science ®Google Scholar
• Leone, G., J. DeGregori, R. Sears, L. Jakoi, and J. R. Nevins. 1997. Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F. Nature 387: 422–426.
   PubMed Web of Science ®Google Scholar
• Lipinski, M. M., and T. Jacks. 1999. The retinoblastoma gene family in differentiation and development. Oncogene 18: 7873–7882.
   PubMed Web of Science ®Google Scholar
• Liu, Y., and E. Zacksenhaus. 2000. E2F1 mediates ectopic proliferation and stage-specific p53-dependent apoptosis but not aberrant differentiation in the ocular lens of Rb deficient fetuses. Oncogene 19: 6065–6073.
   PubMedGoogle Scholar
• Lu, X., and H. R. Horvitz. 1998. lin-35 and lin-53, two genes that antagonize a C. elegans Ras pathway, encode proteins similar to Rb and its binding protein RbAp48. Cell 95: 981–991.
   PubMedGoogle Scholar
• Lyons, G. E., S. Muhlebach, A. Moser, R. Masood, B. M. Paterson, M. E. Buckingham, and J. C. Perriard. 1991. Developmental regulation of creatine kinase gene by myogenic factors in embryonic mouse and chick skeletal muscle. Development 113: 1017–1029.
   PubMedGoogle Scholar
• Malumbres, M., and A. Pellicer. 1998. Ras pathways to cell cycle control and cell transformation. Front. Biosci. 3: d887-d912.
   PubMed Web of Science ®Google Scholar
• Marshall, C. J. 1996. Ras effectors. Curr. Opin. Cell Biol. 8: 197–204.
   PubMed Web of Science ®Google Scholar
• Mittnacht, S., H. Paterson, M. F. Olson, and C. J. Marshall. 1997. Ras signalling is required for inactivation of tumour suppressor pRb cell-cycle control protein. Curr. Biol. 7: 219–221.
   PubMed Web of Science ®Google Scholar
• Nakajima, T., S. Kinoshita, T. Sasagawa, K. Sasaki, M. Naruto, and T. Kishimoto. 1993. Phosphorylation at threonine-235 by a ras-dependent mitogen-activated protein kinase cascade is essential for transcription factor NF-IL6. Proc. Natl. Acad. Sci. USA 90: 2207–2211.
   PubMed Web of Science ®Google Scholar
• Novitch, B. G., G. J. Mulligan, T. Jacks, and A. B. Lassar. 1996. Skeletal muscle cells lacking the retinoblastoma protein display defects in muscle gene expression and accumulate in S and G2 phases of the cell cycle. J. Cell Biol. 135: 441–456.
   PubMed Web of Science ®Google Scholar
• Novitch, B. G., D. B. Spicer, P. S. Kim, W. L. Cheung, and A. B. Lassar. 1999. pRb is required for MEF2-dependent gene expression as well as cell-cycle arrest during skeletal muscle differentiation. Curr. Biol. 9: 449–459.
   PubMed Web of Science ®Google Scholar
• Olson, E. N., G. Spitz, and M. A. Tainsky. 1987. The oncogenic forms of N-ras and H-ras prevent skeletal myoblast differentiation. Mol. Cell. Biol. 7: 2104–2111.
   PubMed Web of Science ®Google Scholar
• Page, B. D., S. Guedes, D. Waring, and J. R. Pries. 2001. The C. elegans E2F- and DP-related proteins are required for embryonic asymmetry and negatively regulate Ras/MAPK signaling. Mol. Cell 7: 451–460.
   PubMedGoogle Scholar
• Peeper, D. S., T. M. Upton, M. H. Ladha, E. Neuman, J. Zalvide, R. Bernards, J. A. DeCaprio, and M. E. Ewen. 1997. Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein. Nature 386: 177–181.
   PubMed Web of Science ®Google Scholar
• Perry, R. L. S., M. H. Parker, and M. A. Rudnicki. 2001. Activated MEK1 binds the nuclear MyoD transcriptional complex to repress transactivation. Mol. Cell 8: 291–301.
   PubMed Web of Science ®Google Scholar
• Ramocki, M. B., S. E. Johnson, M. A. White, C. L. Ashendel, S. F. Konieczny, and E. J. Taparowsky. 1997. Signaling through mitogen-activated protein kinase and Rac/Rho does not duplicate the effects of activated Ras on skeletal myogenesis. Mol. Cell. Biol. 17: 3547–3555.
   PubMed Web of Science ®Google Scholar
• Ramocki, M. B., M. A. White, S. F. Konieczny, and E. J. Taparowsky. 1998. A role for RalGDS and a novel Ras effector in the Ras-mediated inhibition of skeletal myogenesis. J. Biol. Chem. 273: 17696–17701.
   PubMedGoogle Scholar
• Raptis, L., H. L. Brownell, M. J. Corbley, K. W. Wood, D. Wang, and T. Haliotis. 1997. Cellular ras gene activity is required for full neoplastic transformation by the large tumor antigen of SV40. Cell Growth Diff. 8: 891–901.
   PubMedGoogle Scholar
• Sasahara, R. M., C. Takahashi, and M. Noda. 1999. Involvement of the Sp1 site in ras-mediated downregulation of the RECK metastasis suppressor gene. Biochem. Biophys. Res. Commun. 264: 668–675.
   PubMed Web of Science ®Google Scholar
• Sassoon, D., G. Lyons, W. E. Wright, V. Lin, A. Lassar, H. Weintraub, and M. Buckingham. 1989. Expression of two myogenic regulatory factors myogenin and MyoD1 during mouse embryogenesis. Nature 341: 303–307.
   PubMed Web of Science ®Google Scholar
• Schneider, J. W., W. Gu, L. Zhu, V. Mahdavi, and B. Nadal-Ginard. 1994. Reversal of terminal differentiation mediated by p107 in Rb−/− muscle cells. Science 264: 1467–1471.
   PubMed Web of Science ®Google Scholar
• Screpanti, V. A., M. Maroder, E. Petrangeli, L. Frati, and A. Gulino. 1989. Tumor-promoting phorbol ester and ras oncogene expression inhibit the glucocorticoid-dependent transcription from the mouse mammary tumor virus long terminal repeat. Mol. Endocrinol. 3: 1659–1665.
   PubMedGoogle Scholar
• Sears, R. C., and J. R. Nevins. 2002. Signaling networks that link cell proliferation and cell fate. J. Biol. Chem. 277: 11617–11620.
   PubMedGoogle Scholar
• Sellers, W. R., and W. G. J. Kaelin. 1997. Role of the retinoblastoma protein in the pathogenesis of human cancer. J. Clin. Oncol. 15: 3301–3312.
   PubMed Web of Science ®Google Scholar
• Sellers, W. R., B. G. Novitch, S. Miyake, A. Heith, G. A. Otterson, F. J. Kaye, A. B. Lassar, and W. G. J. Kaelin. 1998. Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor growth. Genes Dev. 12: 96–106.
   Google Scholar
• Singh, P., J. Coe, and W. Hong. 1995. A role for the retinoblastoma protein in potentiating transcriptional activation of the glucocorticoid receptor. Nature 374: 562–565.
   PubMedGoogle Scholar
• Takahashi, C., N. Akiyama, T. Matsuzaki, S. Takai, H. Kitayama, and M. Noda. 1996. Characterization of a human MSX-2 cDNA and its fragment isolated as a transformation suppressor gene against v-Ki-ras oncogene. Oncogene 12: 2137–2146.
   PubMed Web of Science ®Google Scholar
• Thomas, D. M., S. A. Carty, D. M. Piscopo, J.-S. Lee, W.-F. Wang, W. C. Forrester, and P. W. Hinds. 2001. The retinoblastoma protein acts as a transcriptional coactivator required for osteogenic differentiation. Mol. Cell 8: 303–316.
   PubMed Web of Science ®Google Scholar
• Tiemann, F., K. Masunuru, and P. W. Hinds. 1997. The retinoblastoma tumour suppressor protein and cancer, p. 163–185. In D. M. Swallow and Y. H. Edwards (ed.), Protein dysfunction and human genetic disease. BIOS Scientific Publishers, Oxford, United Kingdom.
   Google Scholar
• Trimarchi, J. M., and J. A. Lees. 2001. Sibling rivalry in the E2F family. Nat. Rev. Mol. Cell Biol. 3: 11–20.
   Google Scholar
• Tsai, K. Y., Y. Hu, K. F. Macleod, D. Crowley, L. Yamasaki, and T. Jacks. 1998. Mutation of E2f-1 suppresses apoptosis and inappropriate S phase entry and extends survival of Rb-deficient mouse embryos. Mol. Cell 2: 293–304.
   PubMed Web of Science ®Google Scholar
• Umanoff, H., W. Edelmann, A. Pellicer, and R. Kucherlapati. 1995. The murine N-ras gene is not essential for growth and development. Proc. Natl. Acad. Sci. USA 92: 1709–1713.
   PubMed Web of Science ®Google Scholar
• Vooijs, M., and A. Berns. 1999. Developmental defects and tumor predisposition in Rb mutant mice. Oncogene 18: 5293–5303.
   PubMedGoogle Scholar
• Weinberg, R. 1993. Tumor suppressor genes. Neuron 11: 191–196.
   PubMedGoogle Scholar
• Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81: 323–330.
   PubMed Web of Science ®Google Scholar
• Wu, L., A. de Bruin, H. I. Saavedra, M. Starovic, A. Trimboli, Y. Yang, J. Opavska, P. Wilson, J. C. Thompson, M. C. Ostrowski, T. J. Rosol, L. A. Woollett, M. Weinstein, J. C. Cross, M. L. Rosinson, and G. Leone. 2003. Extra-embryonic function of Rb is essential for embryonic development and viability. Nature 421: 942–947.
   PubMed Web of Science ®Google Scholar
• Yochem, J., M. Sundaram, and M. Han. 1997. Ras is required for a limited number of cell fates and not for general proliferation in Caenorhabditis elegans. Mol. Cell. Biol. 17: 2716–2722.
   PubMedGoogle Scholar
• Zacksenhaus, E., Z. Jiang, D. Chung, J. D. Marth, R. A. Phillips, and B. L. Gallie. 1996. pRb controls proliferation, differentiation, and death of skeletal muscle cells and other lineages during embryogenesis. Genes Dev. 10: 3051–3064.
   PubMed Web of Science ®Google Scholar
• Ziebold, U., T. Reza, A. Caron, and J. A. Lees. 2001. E2F3 contributes both to the inappropriate proliferation and to the apoptosis arising in Rb mutant embryos. Genes Dev. 15: 386–391.
   PubMed Web of Science ®Google Scholar